Old Web
English
Sign In
Acemap
>
authorDetail
>
Cameron Wilson
Cameron Wilson
Hoffmann-La Roche
Internal medicine
Oncology
Medicine
Venetoclax
Minimal residual disease
2
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Five-Year Analysis of Murano Study Demonstrates Enduring Undetectable Minimal Residual Disease (uMRD) in a Subset of Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Patients (Pts) Following Fixed-Duration Venetoclax-Rituximab (VenR) Therapy (Tx)
2020
Blood
Arnon P. Kater
Thomas J. Kipps
Barbara Eichhorst
Peter Hillmen
James DRozario
Carolyn Owen
Sarit Assouline
Nicole Lamanna
T. Robak
Javier de la Serna
Ulrich Jaeger
Guillaume Cartron
Marco Montillo
Clemens Mellink
Brenda Chyla
Cameron Wilson
Jenny Wu
Yanwen Jiang
Marcus Lefebure
Michelle Boyer
John F. Seymour
Show All
Source
Cite
Save
Citations (19)
Clonal Dynamics after Venetoclax-Obinutuzumab Therapy: Novel Insights from the Randomized, Phase 3 CLL14 Trial
2020
Blood
Othman Al-Sawaf
Can Zhang
Sandra Robrecht
Cameron Wilson
Maneesh Tandon
Travers Ching
Anna Maria Fink
Matthias Ritgen
Eugen Tausch
Karl Anton Kreuzer
William Schary
Clemens-Martin Wendtner
Barbara Eichhorst
Stephan Stilgenbauer
Yanwen Jiang
Michael Hallek
Kirsten Fischer
Show All
Source
Cite
Save
Citations (14)
1